TY - JOUR
T1 - The International Working Group on Neurotransmitter related Disorders (iNTD)
T2 - A worldwide research project focused on primary and secondary neurotransmitter disorders
AU - Opladen, Thomas
AU - Cortès-Saladelafont, Elisenda
AU - Mastrangelo, Mario
AU - Horvath, Gabriella
AU - Pons, Roser
AU - Lopez-Laso, Eduardo
AU - Fernández-Ramos, Joaquín A.
AU - Honzik, Tomas
AU - Pearson, Toni
AU - Friedman, Jennifer
AU - Scholl-Bürgi, Sabine
AU - Wassenberg, Tessa
AU - Jung-Klawitter, Sabine
AU - Kuseyri, Oya
AU - Jeltsch, Kathrin
AU - Kurian, Manju A.
AU - Garcia-Cazorla, Àngels
N1 - Publisher Copyright:
© 2016 The Authors
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Introduction Neurotransmitters are chemical messengers that enable communication between the neurons in the synaptic cleft. Inborn errors of neurotransmitter biosynthesis, breakdown and transport are a group of very rare neurometabolic diseases resulting in neurological impairment at any age from newborn to adulthood. Methods and results The International Working Group on Neurotransmitter related Disorders (iNTD) is the first international network focusing on the study of primary and secondary neurotransmitter disorders. It was founded with the aim to foster exchange and improve knowledge in the field of these rare diseases. The newly established iNTD patient registry for neurotransmitter related diseases collects longitudinal data on the natural disease course, approach to diagnosis, therapeutic strategies, and quality of life of affected patients. The registry forms the evidence base for the development of consensus guidelines for patients with neurotransmitter related disorders. Conclusion The iNTD network and registry will improve knowledge and strengthen research capacities in the field of inborn neurotransmitter disorders. The evidence-based guidelines will facilitate standardized diagnostic procedures and treatment approaches.
AB - Introduction Neurotransmitters are chemical messengers that enable communication between the neurons in the synaptic cleft. Inborn errors of neurotransmitter biosynthesis, breakdown and transport are a group of very rare neurometabolic diseases resulting in neurological impairment at any age from newborn to adulthood. Methods and results The International Working Group on Neurotransmitter related Disorders (iNTD) is the first international network focusing on the study of primary and secondary neurotransmitter disorders. It was founded with the aim to foster exchange and improve knowledge in the field of these rare diseases. The newly established iNTD patient registry for neurotransmitter related diseases collects longitudinal data on the natural disease course, approach to diagnosis, therapeutic strategies, and quality of life of affected patients. The registry forms the evidence base for the development of consensus guidelines for patients with neurotransmitter related disorders. Conclusion The iNTD network and registry will improve knowledge and strengthen research capacities in the field of inborn neurotransmitter disorders. The evidence-based guidelines will facilitate standardized diagnostic procedures and treatment approaches.
KW - Database
KW - Dopamine
KW - GABA
KW - Glycine
KW - Guideline
KW - Network
KW - Neurotransmitter
KW - Patient registry
KW - Serine
KW - Serotonin
UR - http://www.scopus.com/inward/record.url?scp=84991799985&partnerID=8YFLogxK
U2 - 10.1016/j.ymgmr.2016.09.006
DO - 10.1016/j.ymgmr.2016.09.006
M3 - Article
C2 - 27830117
AN - SCOPUS:84991799985
SN - 2214-4269
VL - 9
SP - 61
EP - 66
JO - Molecular Genetics and Metabolism Reports
JF - Molecular Genetics and Metabolism Reports
ER -